Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Allergy & Immunology
•
Food Allergy
How do you decide to drop the dose of the allergen after a patient has successfully completed OIT?
How do OIT allergists approach post-desensitization maintenance and tapering in practice?
Related Questions
How are you diagnosing chronic FPIES in adults?
Are you initiating/discussing peanut OIT in most children less than age 2 due to the benefits of desensitization and remission?
Do you reflexively test for tree nut allergies when you diagnose a peanut allergy?
Do the recently published results from OUtMATCH 2 change your approach to using Xolair for possible food allergy resolution?
Is the timing of childhood eczema onset useful as a prognostic factor in predicting food allergy tolerance?
Based upon recently published information in the journal Science, would you offer zileuton to a high-risk food allergy patient who declines oral immunotherapy and omalizumab?
Is there any way to perform a baked egg challenge in an infant, or best to wait until developmentally able to consume baked egg?
Are your performing food challenges prior to starting OIT or omalizumab to determine if these patients have a threshold dose that would actually benefit from the intervention?
Is it necessary to test both english walnut and black walnut when evaluating for a walnut allergy?
Do you consider the efficacy of different nasal sprays when prescribing for allergic rhinitis or conjunctivitis?